Abstract Earlier investigations showed a positive correlation between basal cytosolic free calcium in human platelets and blood pressure; however, recent studies have failed to show this relation. We undertook the present work to examine which platelet cytosolic calcium parameters (namely, cytosolic calcium in resting or stimulated states in calcium-containing and calcium-free media) present the least variability and best correlation with blood pressure. We studied 17 healthy white men on three different occasions separated by 1-and 4-week intervals. Their manual and ambulatory automated 24-hour blood pressure measurements were correlated with cytosolic calcium in resting and stimulated (thrombin-treated) fura 2-loaded platelets. The following cytosolic calcium parameters were measured in 1 mmol/L calcium and calcium-free media: basal cytosolic calcium, peak thrombin-evoked cytosolic calcium, and posttransient cytosolic calcium 5 minutes after thrombin treatment. The highest and lowest coefficients of variation were respectively shown by the basal cytosolic calcium (22.8%) and peak thrombin-evoked cytosolic calcium (10.1%) in calcium medium. Basal cytosolic calcium did not correlate with any of the blood pressure parameters. Of the cytosolic H uman platelets have been used as a cellular model for the examination of alterations in cytosolic free calcium (Caj) regulation in essential hypertension. 19 To study these cells most investigations have used fluorescence probes (eg, quin 2 and fura 2), which gain access into the cytosol without disrupting the integrity of the plasma membrane. Although the consensus of earlier studies had been that the Ca, of resting platelets (ie, basal Ca, [BCa,]) is higher in some patients with essential hypertension, more recent reports have shown a substantial overlap of BCa, in normotensive and hypertensive individuals, with few or small differences between the groups. 6 ' 7 ' 911 Moreover, controversy exists concerning the relation between BCa, and systemic blood pressure. 1 -3 -9 Several possibilities could account for these diverse observations. First, isolated blood pressure measurements at the office or clinic may poorly reflect the overall profile of systemic blood pressure and thus poorly correlate with platelet Ca,. Second, a substantial scatter of Ca, levels may exist Received May 26, 1993; accepted in revised form February 23, 1994.
Blood Pressure Inversely Correlates With Thrombin-Evoked Calcium Rise in Platelets
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Correspondence to Dr J. Gardner, PhD, Hypertension Research Center, UMDNJ-New Jersey Medical School, 185 S Orange Ave, Newark, NJ 07103. calcium parameters, peak thrombin-evoked cytosolic calcium in calcium medium demonstrated consistent (negative) correlations with blood pressure, with better correlations shown with diastolic than systolic blood pressure of both automated and manual blood pressure readings. Peak thrombin-evoked cytosolic calcium in calcium medium showed similar correlations with nighttime and daytime automated blood pressure measurements. There were no correlations between peak thrombin-evoked cytosolic calcium in calcium-free medium and blood pressure. However, the difference between peak thrombin-evoked cytosolic calcium in calcium and calcium-free media showed negative correlations with blood pressure. These findings indicate that basal cytosolic calcium in platelets correlates poorly with blood pressure. The inverse relation between peak thrombin-evoked cytosolic calcium increase and blood pressure suggests enhanced platelet calcium extrusion and/or sequestration capacity with increased blood pressure, probably reflecting an accelerated platelet calcium turnover rate with a higher blood pressure in vivo. The present study was designed to identify the Ca, parameter in resting or stimulated platelets (in calcium-containing and calcium-free media) with the least variability and best correlation with systemic blood pressure.
Methods

General Procedures
We studied 17 healthy white men on no medications (including aspirin or nonsteroidal anti-inflammatory agents). The mean (±SEM) age was 44.8+2.0 years, and body mass index (BMI) was 26.7±0.6 kg/m 2 . Each individual was carefully questioned concerning family history of essential hypertension and non-insulin-dependent diabetes mellitus (in parents and siblings) and studied on three occasions separated by 1-week and then by 1-month intervals. On each occasion three blood pressure measurements were obtained between 7 and 8:30 AM with a mercury sphygmomanometer. Measurements were taken at 1-minute intervals with the subject in a sitting position after 5 to 10 minutes of rest, and the mean value of these measurements was recorded (M,). An ambulatory blood pres-sure monitor (No. 90207, SpaceLabs Inc) was subsequently applied to the nondominant arm for 24-hour monitoring. The instrument was programmed to obtain blood pressure measurements at 30-minute intervals between 8 AM and 10 PM and at hourly intervals between 10 PM and 8 AM. Three manual blood pressure measurements were then repeated the next morning (after the 24-hour monitoring) as described above, and the mean value (M 2 ) was recorded. At that time 50 mL of venous blood was withdrawn for measurement of platelet Ca, parameters. Informed consent, approved by the Institutional Review Board, was obtained from all subjects.
Platelet Isolation and Measurement of Ca,
Blood was drawn from the antecubital vein of the dominant arm into acid dextrose buffer (20:1, vol/vol) consisting of (final concentration in mmol/L) sodium citrate 14, citric acid 11.8, and dextrose 18 (pH 6.5). Platelet-rich plasma was obtained by centrifugation at 200g for 10 minutes at room temperature. This fraction was centrifuged at lOOOg for 10 minutes, and cells were washed two times in buffer containing (mmol/L) NaCI 140, KC1 5, glucose 10, HEPES 20, EGTA 0.1, and aspirin 0.1 (pH 7.4). Fatty acid-free bovine serum albumin (BSA, 0.1%) was added to the last washing.
Platelets were incubated with 5 /imol/L fura 2-AM (Molecular Probes) for 30 minutes (37°C) in HEPES-bufFered solution (HBS) consisting of (mmol/L) NaCI 140, KC1 5, MgCl 2 1, CaCl 2 1, glucose 10, and HEPES 20 as well as 0.1% BSA (pH 7.4). Immediately before experiments aliquots of dye-loaded platelets (100 fih of 1 to 3x 10 6 cells) were rapidly centrifuged to remove extracellular dye. Platelets were resuspended in 80 iL of calcium-HBS (HBS containing 1 mmol/L CaCl 2 ) and injected into 3 mL of buffer. In experiments performed in the absence of extracellular calcium, platelets were resuspended in calcium-free HBS (HBS containing 0.3 mmol/L EGTA substituted for CaCl 2 ). After 16 seconds of incubation, 0.1 U/rnL human a-thrombin (No. 9135, Sigma Chemical Co) was added, and the change in the Ca, profile was monitored for an additional 300 seconds. Cai measurements were performed in a Fluorolog II spectrophotometer (model CM-3, SPEX Industries) equipped with a thermostatically controlled (37°C) cuvette holder and stirrer, as previously described for fura 2 measurements. 18 Excitation and emission wavelengths were 340/380 and 505 nm, respectively, and data were collected at 2-second intervals.
All platelet preparations responded to thrombin; the Ca, profile was characterized by a typical brisk increase in Ca! to a peak value followed by a gradual decline to basal levels. As fura 2 is not completely eliminated by a single centrifugation, BCa, in calcium-HBS was measured immediately after addition of 0.5 mmol/L MnCl 2 to resuspended platelets. BCa; (in calcium-free HBS), peak Ca, (PCai), and Ca^ 5 minutes after addition of thrombin (5-minute Ca,) in 1 mmol/L calcium-HBS or calcium-free HBS were averaged from duplicate experiments. Intra-assay variability for PCaj in calcium-HBS and calcium-free HBS (ie, the difference between the two PCa, values of duplicate experiments) was less than 9% of the thrombin-evoked change in Ca^ In preliminary experiments we determined the rate of fura 2 leakage from cells to be less than 10% per hour. To eliminate the effects of dye leakage on Ca, determinations after exposure to thrombin, we obtained 
Statistical Analysis
Because of technical problems blood samples for measurement of Caj parameters from one subject were studied on only a single occasion. Unless otherwise indicated mean values represent the measurements from 17 individuals, and coefficients of variation are from three measurements obtained from 16 individuals. All statistical analyses were performed on an IBM-compatible personal computer with the SAS statistical analysis package (SAS Institute). ANOVA (PROC GLM) was first performed to assess the consistency of measurements on the three occasions relative to variability across individuals. Mean blood pressure measurements and Ca, parameters were computed for each individual. Bivariate correlations were then computed with means using SAS PROC CORR and are reported with two-tailed probability values. These correlations are conservative, in that estimation of the correlation based on means will tend to understate the relation if a correlation also exists within individuals. The criterion for statistical significance wasP<.05.
Results
Blood pressure parameters for the group are summarized in Table 1 . Low coefficients of variation (£4%) were observed for both the manual and ambulatory (automatic) blood pressure measurements. The means of the 24-hour systolic blood pressure, daytime systolic blood pressure, and nighttime systolic blood pressure showed low coefficients of variation (-2.5%), whereas the nighttime diastolic blood pressure showed the highest coefficient of variation (4.0%). In general, manual blood pressure measurements manifested higher coefficients of variation than the 24-hour and daytime ambulatory values.
In contrast to the low coefficients of variation of the blood pressure measurements, all platelet Ca; parameters demonstrated coefficients of variation greater than 10% ( Table 2 ). The highest and lowest coefficients of variation were demonstrated by the BCa, in calcium-HBS (22.8%) and the PCa, in calcium-HBS [PCa,( + )] (10.1%).
Separate ANOVA on blood pressure and Ca, parameters showed no systematic shifts among the three measurements. Furthermore, within each subject differences in blood pressure and Ca, measurements from one occasion to the other were small (as assessed by ANOVA; see Tables 1 and 2 ) and represented only a small portion of overall variability across individuals. Thus, the correlations between Ca, and blood pressure were similar on each occasion. All reported correlation coefficients between blood pressure measurements and Caj values are from the means of three observations. BCa, in calcium-HBS showed no correlation with any of the blood pressure measurements (eg, for daytime ambulatory systolic blood pressure,/•= -.18 and/ ) =.48). Of the Ca, parameters, only the thrombin-evoked PCa,(+) demonstrated significant (negative) correlations with blood pressure parameters. In general, better correlations were observed between PCa,(+) and diastolic blood pressure than systolic pressure. Figs 1  through 4 show the relation between the mean values of Ca, and blood pressure measurements and their calculated regression coefficients and probability value (estimated), in addition to the first, second, and third measurement values. There were no apparent correlations between the PCa, response in calcium-free medium [PCa,( -)] and blood pressure parameters. For instance, the mean of the 2-day systolic blood pressure measurements (M, + M 2 /2), which had the best correlation of all blood pressure measurements with PCa,(-), had an r value of .37 (/>=.14). However, the difference between PCa ; ( + ) and PCa,(-) (APCa,), representing the effect of external calcium entry on the thrombinevoked Ca ( change, showed the same or better correlation with most of the blood pressure parameters compared with PCaj(-l-). Fig 1 depicts the correlation between PCa,(-l-) and APCa, with the manual measurements of diastolic blood pressure on the morning ending the 24-hour blood pressure monitoring (M 2 ) and with the mean 2-day diastolic blood pressure measurements. Not shown in this figure are the correlations between the Ca, parameters and systolic blood pressure (M 2 ) and the mean of the 2-day systolic blood pressure measurements (M! + M 2 /2), which were as follows: for M 2 with PCai(-l-), r = -. 3 3 , P=.2O and with APCa,, r=-.56, P=.02; for M, + M 2 /2 with PCa,(+), r=-.21, P=A2 and with APCa,, r=-.56, P=.Q2. It is clear that APCa, showed better correlation than PCa,( + ) with manual systolic or diastolic blood pressure measurements, and also a better correlation exists between PCai(-l-) and APCa, with diastolic than systolic blood pressure.
Figs 2 and 3 summarize the correlation between PCa,(+) and daytime and nighttime ambulatory blood pressure measurements, respectively. In general, PCai(+) correlated to the same degree with nighttime and daytime blood pressure values. However, PCa^-l-) demonstrated stronger correlations with diastolic than systolic blood pressure. Better correlations were noted for daytime blood pressure values with APCai than with PCaj(-l-) (compare Figs 2 and 4) . However, the correla- tions for nighttime blood pressure with APCaj versus nighttime diastolic blood pressure, r = -. 6 2 , P=.OO8; versus nighttime systolic blood pressure, r= -.46, P=.O6; versus nighttime mean arterial pressure, r=-.58, P=.Ol) were essentially the same as with PCa,(+) (compare Fig 3) . As expected, correlations of PCa,(+) and APCai with mean arterial pressure were intermediate of the systolic and diastolic blood pressure correlations. There were no effects of family history of hypertension and non-insulin-dependent diabetes mellitus, age, and BMI on Cai parameters. BMI was significantly and positively correlated with the M!+M 2 /2 measurements of diastolic (r=.59) and systolic (r=.55) blood pressure (P=.O1 and .02, respectively). BMI was not correlated with the age of the subjects in this population (r=.16, P=.5A).
Discussion
This study shows that platelet BCai exhibits the greatest variability among the Ca, parameters and that no correlation exists with systolic or diastolic blood pressure values in a group of 17 white men who (except for one subject) underwent repeated blood pressure and platelet Caj measurements on three different occasions. Thus, it is questionable whether platelet BCa; can be useful in studying mechanisms underlying essential hypertension or in predicting the predisposition to this disease. Although elevated BCa, was observed in patients with essential hypertension, a number of studies have not been able to show a positive correlation between blood pressure and platelet BCa,. 3911 - 20 Erne et al 1 and Brickman et al 13 did observe such a relation, but the latter gTOup showed it only when a large number of subjects were studied. Irrespective of the diagnosis of essential hypertension, blood pressure is continuously distributed. It therefore stands to reason that factors commonly associated with essential hypertension and not elevated blood pressure per se are responsible for the higher BCa;. These factors include dyslipidemia and obesity.
Several forms of dyslipidemia are associated with elevated BCa, and marked by increased platelet reactivity. 2123 Moreover, both abnormal blood lipid profiles 24 and hyperactive platelets 25 ' 26 are observed in some patients with essential hypertension. Thus, elevated platelet BCa, in some essential hypertensive patients with increased platelet reactivity might be related to their abnormal lipid profile or artifacts resulting from enhanced platelet activation during platelet isolation. In addition, although no correlations have been observed between BMI and platelet BCa,, platelets from obese hypertensive patients demonstrate a significant drop in BCa, levels with weight reduction. 1617 Conclusions concerning the relation between platelet BCa, and blood pressure are further complicated by observations that blacks and women show lower BCa, than whites and men, respectively, 912 ' 13 and the finding by some that BCa, correlates positively with age. 6 Platelet BCai level depends to a large extent on the methods used for platelet isolation and analysis. Variables in these procedures include the agent or agents used for calcium chelation, the duration of calcium repletion after isolation, and the fluorescence probes used for the measurement of this parameter. 27 In this study BCa, in calcium-HBS was obtained immediately after fura 2 loading, in freshly resuspended platelets, and in the absence of extracellular dye (quenched with MnCl 2 ). The range of BCa, values in this study was similar to the generally lower Ca, levels reported in recent studies 4 -1720 using fura 2-loaded platelets. These lower Cai levels probably reflect improved methods of isolating platelets with minimal activation and correction for dye leakage. Nevertheless, the relevance of BCa, in vitro to the in vivo Ca, profile, where Ca, continuously oscillates, 28 -29 is not clear. Also important is the fact that in some patients essential hypertension could relate to perturbations in Ca, homeostasis that are not expressed by elevated BCaj levels. For instance, calcium extrusion is mediated by the calcium pump and sodium-calcium exchange. These systems manifest substantial reserve capacities, and therefore accelerated external calcium entry may be expressed by little or no apparent rise in BCa, but by an enhanced calcium turnover rate. In recent work 30 we confirmed findings of a lower BCa, in platelets of blacks than whites. 913 Yet platelets from blacks showed a higher calcium turnover rate, namely, enhanced calcium entry into and extrusion from the cytosol.
Of the various Ca ; parameters examined in the present work, the peak amplitude of the thrombin-evoked Caj response in calcium-containing medium showed the least variability and the best (negative) correlation with systemic blood pressure. We have selected thrombin as the agonist of choice because it is the most commonly used agent to stimulate platelets through calcium mobilization and enhancement of external calcium entry. However, it is of interest to note that the decline in agonist-evoked Ca, response with increased blood pressure is not unique for thrombin, as it has been recently observed with respect to the treatment of platelets with arginine vasopressin. Dominiczak et al 7 and Miller et al 9 showed that in calcium-containing buffers platelets of patients with essential hypertension had a reduced response to vasopressin compared with platelets from normotensive subjects. As in the present study, blood pressure-related differences were not observed when platelets were treated with vasopressin in calcium-free medium. Thus, the main factor correlating with increased blood pressure is a decline in the agonist-evoked rise in Ca, associated with external calcium entry. The reasons for this finding are not clear. It is possible that diminished agonist-evoked external calcium entry is a phenomenon associated with elevated blood pressure. If this is the case it would be difficult to explain the role of Ca; in increased platelet reactivity (and presumably increased vascular smooth muscle cell activity) in essential hypertension. However, another possibility is that elevated blood pressure may be associated with an increased calcium turnover rate in vivo. Thus, when examined in vitro platelets from individuals with a higher blood pressure would manifest a paradoxical reduction in the agonist-evoked Ca, response due to efficient calcium extrusion and/or sequestrating processes. This enhanced calcium turnover rate may not be expressed in calcium-free medium, as calcium mobilization from intracellular organelles is insufficient to uncover the increased efficiency of the calcium extrusion and/or sequestrating processes associated with increased blood pressure. If essential hypertension in some patients is associated with an increased calcium turnover rate, it is possible that the frequency of Cai oscillations in vivo is more important than the amplitude of the agonist-evoked Ca, response as the critical factor playing a role in this disease. It is clear that further investigation should be undertaken to address this issue.
Finally, as essential hypertension is associated with increased platelet reactivity, it is important to minimize platelet activation during their isolation when evaluating Ca, homeostasis. Inhibition of the cyclooxygenase system in these cells helps in this regard and is frequently used to prevent secondary perpetuating responses associated with platelet activation. 31 There is no evidence to our knowledge that aspirin or elements in the cyclooxygenase system directly alter transport processes regulating Cai in platelets, ie, external calcium entry, calcium mobilization and sequestration, and calcium extrusion. Thus, we suggest that the use of aspirin or equivalent agents to isolate platelets from hypertensive (and normotensive) patients is likely to yield a population of cells with fewer activated platelets. Our observation of a negative correlation between the agonist-evoked Caj response in aspirin-treated platelets and blood pressure is similar to observations by others in non-aspirin-treated platelets. 7 ' 9 Apparently, in vitro treatment of platelets with aspirin does not modify blood pressure-related perturbation of Ca, in these cells.
